Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone effects on glucose metabolism and gut microbiota in healthy adults
jRCTs041210165Completed
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of risperidone (2 arms). Primary endpoint: Change in HOMA-IR from baseline to day 5. Started Jul 2022; status: completed.
02
Drugs
risperidone
Beyond the preview
Go deeper on jRCTs041210165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210165.